Latest Health News

Etherstack has landed its eighth contract deploying digital radio technology for the world's largest iron ore producer in Western Australia, reinforcing its foothold in a critical mining communications sector.

Australian Foundation Investment Company (AFIC) reported a 2.7% rise in half-year profit to $154.2 million and increased its interim dividend to 12 cents per share, while its portfolio outpaced the S&P/ASX 200 over the past year.

Audeara has officially launched its Clinico Sound Earbuds CS1 in Taiwan through a strategic partnership with Clinico Inc., marking a key step in its international expansion and tapping into a growing hearing health market.

Emyria Limited announces key leadership shifts with Greg Hutchinson stepping up as Executive Chairman and Dr. Michael Winlo transitioning to Chief Scientific Officer, aiming to scale innovative mental health therapies amid growing demand.

Chrysos Corporation reports a robust Q2 FY25 with a 12% quarter-on-quarter and 53% year-on-year revenue increase, driven by expanding international sales and rising sample volumes. The company secured two new contracts, boosting its PhotonAssay™ footprint and maintaining strong financial health.

West African Resources delivered solid Q4 2024 gold production and maintained full-year guidance, while progressing the Kiaka project on schedule and budget. The company also earned national recognition for its community contributions in Burkina Faso.

Paladin Energy reports its highest monthly uranium production since March 2024 and completes the strategic acquisition of Fission Uranium Corp, expanding its footprint in Canada’s uranium sector.

Paladin Energy Ltd reported a robust quarterly cash flow for Q4 2024, with a net operating cash inflow of $43.3 million and a strong cash position of $117.1 million, underpinning its ongoing projects and financial flexibility.

Wildcat Resources has delivered a landmark Mineral Resource Estimate for its Tabba Tabba Lithium Project, positioning it as a major player in Australia’s lithium sector with a high-confidence 74.1Mt resource at 1.0% Li2O.

Global Health Limited reported a robust 22% increase in customer receipts for the December 2024 quarter, alongside a significant improvement in operating cash flow, positioning the company well amid ongoing healthcare sector challenges.

Recce Pharmaceuticals has successfully dosed all patients in its Phase II trial of RECCE® 327 topical gel for acute bacterial skin infections, showing encouraging preliminary efficacy and safety data. The company is preparing for pivotal Phase III trials in Australia and Indonesia, targeting a significant global market opportunity.

Fulcrum Lithium Ltd has successfully completed its IPO, raising $9.7 million, and commenced drilling at its Alkali Flats lithium project in Nevada, marking a significant step in its exploration journey.